{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:51:17Z","timestamp":1791280277165,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ijpharm.2004.01.019","type":"journal-article","created":{"date-parts":[[2004,2,27]],"date-time":"2004-02-27T10:21:49Z","timestamp":1077877309000},"page":"167-183","source":"Crossref","is-referenced-by-count":171,"title":["Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis"],"prefix":"10.1016","volume":"274","author":[{"given":"H.M","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B","family":"Deasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ziaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Claffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2004.01.019_BIB1","unstructured":"American Academy of Periodontology, 1996. Systemic antibiotics in periodontics. J. Periodontol. 67, 831\u2013838."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-051X.1985.tb00917.x","article-title":"Susceptibility of human oral anaerobic bacteria to antibiotics suitable for topical use","volume":"12","author":"Baker","year":"1985","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-5173(96)04649-2","article-title":"Comparative analysis of tetracycline containing dental gels: poloxamer and monoglyceride based formulations","volume":"142","author":"Esposito","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(99)00040-5","article-title":"Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide","volume":"48","author":"Ganza-Gonz\u00e1lez","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0168-3659(87)90002-2","article-title":"The effect of solutes and polymers on the gelation properties of pluronic F127 solutions for controlled drug delivery","volume":"5","author":"Gilbert","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1902\/jop.1983.54.10.575","article-title":"Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets","volume":"54","author":"Goodson","year":"1983","journal-title":"J. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1902\/jop.1990.61.11.686","article-title":"Efficacy of clindamycin hydrochloride in refractory peridontitis: 24 months result","volume":"61","author":"Gordon","year":"1990","journal-title":"J. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0765.1991.tb02075.x","article-title":"Multicenter evaluation of tetracycline fiber therapy: 1. Experimental design, methods and baseline data","volume":"26","author":"Goodson","year":"1991","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1600-051X.1998.tb02397.x","article-title":"The use of locally delivered chlorhexidine in the treatment of periodontitis. Clinical results","volume":"25","author":"Killoy","year":"1998","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0021-9673(00)95294-4","article-title":"Mechanism of reversed-phase separation of tetracyclines by high-performance liquid chromatography","volume":"186","author":"Knox","year":"1979","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB11","unstructured":"Levis, S., 2000. Novel Pharmaceutical Excipients. Ph.D. Thesis, Trinity College, University of Dublin."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0765.1995.tb02136.x","article-title":"In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria","volume":"30","author":"Miyake","year":"1995","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1902\/jop.1998.69.5.578","article-title":"Retention, antimicrobial activity and clinical outcomes following use of a bioerodible tetracycline gel in moderate to deep periodontal pockets","volume":"69","author":"Needleman","year":"1998","journal-title":"J. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-051X.1992.tb02529.x","article-title":"Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease","volume":"19","author":"Norling","year":"1992","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/02652040010019532","article-title":"In vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dinucleotide from halloysite a cylindrical material","volume":"18","author":"Price","year":"2001","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB16","first-page":"217","article-title":"Adhesives in opthalmology: a review","volume":"15","author":"Refojo","year":"1971","journal-title":"Surv. Opthalmol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-051X.1996.tb00551.x","article-title":"Histological and microbiological aspects of ligature induced periodontitis in beagle dogs","volume":"23","author":"Renvert","year":"1996","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0376-7388(98)00311-1","article-title":"Controlled release of glucose through modified chitosan membranes","volume":"155","author":"Singh","year":"1999","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB19","first-page":"421","article-title":"Principles and clinical applications of periodontal controlled drug delivery with tetracycline fibers","volume":"14","author":"Tonetti","year":"1994","journal-title":"Int. J. Periodontol. Res. Dent."},{"key":"10.1016\/j.ijpharm.2004.01.019_BIB20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-051x.2000.027002079.x","article-title":"Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis","volume":"27","author":"Van Winkelhoff","year":"2000","journal-title":"J. Clin. Periodontol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T23:23:26Z","timestamp":1550186606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517304000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0378517304000353"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2004.01.019","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}